Tag: drug safety
-
UK Crime Gangs Move Into Branded Weight-Loss Drugs, Raising Public Health Alarm
Overview: A growing threat to public health Authorities in the United Kingdom have issued a stark warning: organised crime groups are increasingly manufacturing their own branded weight-loss drugs and distributing them as if they were legitimate medicines. The emergence of this homegrown illicit supply chain raises serious concerns about safety, efficacy and the broader risks…
-
Public Health Sudbury Issues Urgent Drug Alert Over Heavier Sedation in Local Overdoses
Public Health Sudbury Issues Urgent Drug Alert Over Heavier Sedation in Local Overdoses Public Health Sudbury and Districts, in collaboration with Sudbury’s Community Drug Strategy, has issued a warning to residents about a troubling trend: recent drug poisonings in the Sudbury area have involved heavier levels of sedation, and authorities are uncertain why this shift…
-
MedSafetyWeek 2024: MHRA Urges Public to Report Side Effects and Suspected Fake Medicines
What is MedSafetyWeek and why it matters MedSafetyWeek is an international initiative now in its tenth year, uniting more than 130 medicines regulators and health organisations across 117 countries. The campaign emphasizes the importance of public participation in pharmacovigilance: reporting suspected side effects from medicines and incidents involving medical devices. When people share experiences with…
-
MHRA Urges Public to Report Medicine Side Effects and Suspect Counterfeits During MedSafetyWeek
Overview: MedSafetyWeek Spotlight on Medicines Safety As the tenth annual MedSafetyWeek kicks off, regulatory bodies and health organisations from more than 130 regulators across 117 countries unite to emphasise a simple, powerful idea: report safety concerns about medicines and medical devices. The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom is joining…
-
MedSafetyWeek 2025: MHRA Urges Public to Report Side Effects and Suspected Fakes
Why MedSafetyWeek Matters The tenth annual MedSafetyWeek mobilizes regulators, health organisations, and the public in a joint effort to safeguard medicine use worldwide. Coordinated by more than 130 medicines regulators and health bodies across 117 countries, the campaign emphasizes the critical role citizens play in pharmacovigilance. By reporting unexpected side effects and concerns about medicines…
-
FDA Warns of Prasozin Hydrochloride Recall Over Potential Carcinogen in Blood Pressure Medication
Overview: FDA Issues Recall for Prazosin Hydrochloride The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of prazosin hydrochloride, a medication used to treat high blood pressure and related conditions. The action comes after concerns that the drug product may contain a chemical suspected of causing cancer. The recall affects more than…
-
FDA recalls blood pressure med prazosin hydrochloride over potential carcinogen
Overview: FDA recalls prazosin hydrochloride amid carcinogen concerns The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of more than half a million bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing chemical. The affected lots were distributed by Teva Pharmaceutical…
-
FDA Recalls Blood Pressure Drug Prazosin Hydrochloride Over Potential Carcinogen
Overview: FDA Notice on Prazosin Hydrochloride Recall The U.S. Food and Drug Administration (FDA) has announced the recall of more than 500,000 bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing impurity, prompting manufacturers to pull affected lots from the market and instruct patients…
-
Adverse Reactions to Acetaminophen and Ibuprofen in Children: A Narrative Review
Overview: Why a Narrative Review on Pediatric ADRs Matters Acetaminophen and ibuprofen are among the most commonly used over-the-counter medications for fever and pain in children. While their safety profiles are well established when used correctly, reports of suspected adverse drug reactions (ADRs) in pediatric populations have risen in recent years. This trend coincides with…
-
Cannabis, College, and Crisis: My Oxford Breakthrough About Mental Health and the Dangers of Skunk
Introduction: A Quiet Descent Like many middle-class London teens, I started smoking cannabis around age 15. It felt preferable to alcohol, which I found unpalatable, and weed offered a pleasant buzz that seemed safer because it was “natural” and easy to obtain. It was something I associated with parties, never with home or isolation. By…